Accuray Inc (ARAY) stock

ARAYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 3/30

$2.80−0.28 (-9.09%)

Close on Nov 13, 2026Market cap $334.43MP/E –Yield –

Accuray EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Accuray's EV/EBITDA was 36.0× on Jan 30, 2026, against 889.8× a year earlier. Over the last 5 years it ranged from 36.0× to 989.4×, with a median of 544.5×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Jan 30, 2026	36.0×	−0.4
2025	Dec 31, 2025	36.3×	−853.4
2024	Jan 31, 2024	889.8×	−81.6
2023	Dec 29, 2023	971.4×	+71.7
2022	Dec 30, 2022	899.7×	+211.0
2021	Dec 31, 2021	688.7×	+171.8
2020	Dec 31, 2020	517.0×	−382.1
2019	Dec 31, 2019	899.1×	–

Where these numbers come from

Parsed from the XBRL in Accuray's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ARAY.

Compare: ARAY vs PRCT · ARAY vs NVCR · ARAY vs ANGO · ARAY vs LMAT · ARAY vs TCMD

Revenue growth-12.5% · median 12.9%

Gross margin28.0% · median 72.0%

Operating margin-13.1% · median -11.2%

Net margin-4.4% · median -10.1%

Company	Revenue	Growth
NVCR	$725.39M	+12.9%
ARAY	$394.53M	-12.5%
TCMD	$356.42M	+14.4%
PRCT	$352.30M	+17.5%
ANGO	$325.38M	+8.2%
LMAT	$269.36M	+11.8%

Company

Next earnings (est.): Feb 3, 2027, after close
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: June 30
Employees: 809
Held by institutions: 59.9%
Auditor: GRANT THORNTON LLP
SEC CIK: 1138723

Advertisement
300 × 250

See a number that looks wrong?